Validation of a Lateral Flow Assay for Rapid Diagnosis of Histoplasmosis in Advanced HIV Disease, Buenos Aires, Argentina.
HIV
histoplasmosis
lateral flow assay
rapid diagnosis
Journal
Applied microbiology (Basel, Switzerland)
ISSN: 2673-8007
Titre abrégé: Appl Microbiol (Basel)
Pays: Switzerland
ID NLM: 9918821488406676
Informations de publication
Date de publication:
2022
2022
Historique:
medline:
1
1
2022
pubmed:
1
1
2022
entrez:
26
8
2024
Statut:
ppublish
Résumé
Histoplasmosis is a major cause of mortality in individuals with advanced human immunodeficiency virus (HIV) disease (AHD). We evaluated in patients with AHD a lateral flow assay (LFA) developed by MiraVista
Identifiants
pubmed: 39184036
doi: 10.3390/applmicrobiol2040072
pmc: PMC11342866
doi:
Types de publication
Journal Article
Langues
eng
Pagination
950-955Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflict of interest to declare. The reagents have been provided by MiraVista® Diagnostics. On 29 November 2021, Diego H. Caceres became an IMMY employee. The results and conclusions reported in this study belong to the authors and do not necessarily reflect the official views of the U.S. CDC.